MetaCap

Relay Therapeutics Statistics

NASDAQ: RLAYHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

16.12+0.21 (+1.32%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Relay Therapeutics by the numbers

Relay Therapeutics has a market capitalization of $3.56 billion based on 220.96M shares outstanding. With trailing EPS of $-1.50, Relay Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 11.1% below its 50-day average and 2.4% above its 200-day average.

Average daily trading volume is 2.93M shares, or about $47.2 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

RLAY valuation vs. peer median

RLAY compared with the median of 8 peer companies
MetricRLAYPeer medianDifference
Market cap$3.56B$3.07B+16%
Avg. volume2.93M1.89M+55%

Peer median across 8 companies: TARS, CRSP, IOVA, DNLI, VCEL, ADMA, ADPT, BEAM.

Valuation

Price / sales (latest FY)
231.97
EPS (TTM)
$-1.50

Price and trading

Previous close
15.91
Open
15.59
Day range
15.17 – 16.32
52-week range
6.80 – 21.27
52-week change
+138.11%
Beta
—
Volume
3.98M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
3.56B
Forward Pe
-10.26
Eps
-1.50
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
21.27
Week52 Low
6.80
Avg Volume
2.93M
Shares Outstanding
220.96M
Ma50
18.13
Ma200
15.74
Earnings Date
Nov 4, 2026
Pct From52w High
-24.21%
Pct From52w Low
137.06%

Related